- ►annals.org ME Cogswell, SM McDonnell, MJ Khoury, … - Annals of internal …, 1998 - Am Coll Physicians Published clinical research offers little evidence to suggest that population screening for hemochromatosis
done by using genetic testing improves clinical outcomes.Although one recently discovered
mutation, C282Y, accounts for 60% to 92% of cases of the disease in series of patients ... Cited by 117 - Related articles - BL Direct - All 4 versions
- ►bmj.com [PDF] K Vella, C Goldfrad, K Rowan, J Bion, N Black - British Medical Journal, 2000 - bmj.com Introduction The need to involve as many legitimate stakeholders as possible in the identification
and prioritisation of research topics is increasingly being recognised. Not only might such a strategy
ensure that the interests of all relevant people are considered, it might also increase ... Cited by 79 - Related articles - BL Direct - All 5 versions
- ►annals.org SM McDonnell, PD Phatak, V Felitti, A Hover … - Annals of internal …, 1998 - Am Coll Physicians Interest in including screening for hemochromatosis in the routine medical care of adults has
grown in recent years.In March 1997, at a meeting on iron overload at the Centers for Disease
Control and Prevention, the directors of four hemochromatosis screening programs ... Cited by 80 - Related articles - BL Direct - All 4 versions
CE McLaren, JC Barton, PC Adams, EL Harris … - The American journal …, 2003 - journals.lww.com From the Epidemiology Division, College of Medicine, University of California, Irvine, California
(cem); Southern Iron Disorders Center, Birmingham, Alabama (jcb); Department of Medicine,
London Health Sciences Centre, London, Ontario, Canada (pca); Kaiser Permanente ... Cited by 68 - Related articles - BL Direct - All 3 versions
- ►annals.org [PDF] EP Whitlock, BA Garlitz, EL Harris, TL Beil, … - Annals of internal …, 2006 - Am Coll Physicians Purpose: To conduct a focused systematic review of heredita- ry hemochromatosis screening
relating to 2 USPSTF criteria, the burden of suffering and the potential effectiveness of a
preven- tive intervention, to determine whether evidence is sufficient for a USPSTF ... Cited by 55 - Related articles - All 6 versions
- ►chello.nl [PDF] MA McCullen, DHG Crawford, PE Hickman - Clinica Chimica Acta, 2002 - Elsevier Background: Hereditary hemochromatosis is the most common autosomal recessive disorder
in populations of northern European descent. Issues: Many experts consider hemochromatosis
to be an almost ideal disease for population screening because it essentially fulfills ... Cited by 50 - Related articles - All 7 versions
- ►annals.org [PDF] B Schmitt, RM Golub, R Green - Annals of internal medicine, 2005 - Am Coll Physicians Background: Therapeutic phlebotomy for hereditary hemochro- matosis is relatively safe and
presumably efficacious when offered before cirrhosis develops, so screening primary care patients
is of substantial interest. Purpose: To conduct a systematic review of the evidence on 1) ... Cited by 38 - Related articles - BL Direct - All 5 versions
ME Cogswell, W Burke, SM McDonnell, AL Franks - American journal of …, 1999 - Elsevier Context: The discovery of the HFE gene in 1996 has introduced DNA testing as a possible tool
for screening and diagnosis of hemochromatosis and increased interest in the disorder. Population
screening using transferrin saturation has been advocated by experts to permit early ... Cited by 15 - Related articles - BL Direct - All 6 versions
B Hicken, D Tucker - Psychology, Health and Medicine, 2002 - ingentaconnect.com The impact of genetic risk feedback on perceived risk and motivation to follow health recommendations
was investigated to determine if intent to follow recommended screening behaviours would differ
between individuals with family history-based risk estimates and individuals with genetics- ... Cited by 12 - Related articles - BL Direct - All 3 versions
BL Hicken, DA Calhoun, JC Barton, DC Tucker - Genetic Testing, 2004 - liebertonline.com We examined attitudes regarding genetic testing and psychosocial outcomes of HFE genotyping
for he- mochromatosis. A total of 87 persons with hemochromatosis (patients) (39 women, 48
men), who underwent HFE genotyping, and 50 persons with hypertension (controls) (22 ... Cited by 10 - Related articles - BL Direct - All 3 versions
